<p><b>A–C.</b> The chemical structure of Forsythin extracted from <i>Forsythia suspensa</i> seeds. Forsythin is an o-linked β-D-glucopyranosylated lignin that can be hydrolyzed (Red line). <b>D.</b> Predicted docking site of Forsythin with PDE4. <b>E.</b> Predicted residue electrostatic and van der Waals interactions between PDE4 amino acids and Forsythin. Using ZINCPharmer <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0115937#pone.0115937-Koes1" target="_blank">[24]</a>, a pharmacophore model was generated (upper left) and used to screen the lead compounds from an 18.3 million purchasable compound library.</p
[[abstract]]Phosphodiesterase 4D (PDE4D) has been identified be a promising target which associate w...
Pyruvate dehydrogenase kinases (PDKs) are key enzymes in glucose metabolism, negatively regulating p...
Parkinson’s disease (PD) is a neurodegenerative, progressive, and incurable disorder characterized b...
Cyclic adenosine monophosphate (cAMP) is a crucial intracellular second messenger molecule that conv...
Cyclic adenosine monophosphate (cAMP) is a crucial intracellular second messenger molecule that conv...
Cyclic adenosine monophosphate (cAMP) is a crucial intracellular second messenger molecule that conv...
The phosphodiesterase 4 (PDE4) family of enzymes is a promising drug target for a variety of conditi...
<p>cAMP, intracellular cyclic adenosine monophosphate, is a ubiquitous second messenger that plays a...
Parkinson’s disease, caused by mutations in the Parkin that leads to loss of neuron is the second mo...
<p>Microtubule affinity-regulating kinase 4 (MARK4) has recently been identified as a potential drug...
[[abstract]]"Phosphodiesterase superfamily is the key regulator of 3′,5′-cyclic guanosine monophosph...
We studied the pharmacological potential effects of viral components, performed target prediction an...
Parkinson’s disease (PD) is the second most common neurodegenerative disease with a fast-growing pre...
Objective: The objective of this study was to explore the therapeutic role of biomolecules in target...
The 4-hydroxyphenylpyruvate dioxygenase (HPPD) is a relevant target protein for therapeutic and ag...
[[abstract]]Phosphodiesterase 4D (PDE4D) has been identified be a promising target which associate w...
Pyruvate dehydrogenase kinases (PDKs) are key enzymes in glucose metabolism, negatively regulating p...
Parkinson’s disease (PD) is a neurodegenerative, progressive, and incurable disorder characterized b...
Cyclic adenosine monophosphate (cAMP) is a crucial intracellular second messenger molecule that conv...
Cyclic adenosine monophosphate (cAMP) is a crucial intracellular second messenger molecule that conv...
Cyclic adenosine monophosphate (cAMP) is a crucial intracellular second messenger molecule that conv...
The phosphodiesterase 4 (PDE4) family of enzymes is a promising drug target for a variety of conditi...
<p>cAMP, intracellular cyclic adenosine monophosphate, is a ubiquitous second messenger that plays a...
Parkinson’s disease, caused by mutations in the Parkin that leads to loss of neuron is the second mo...
<p>Microtubule affinity-regulating kinase 4 (MARK4) has recently been identified as a potential drug...
[[abstract]]"Phosphodiesterase superfamily is the key regulator of 3′,5′-cyclic guanosine monophosph...
We studied the pharmacological potential effects of viral components, performed target prediction an...
Parkinson’s disease (PD) is the second most common neurodegenerative disease with a fast-growing pre...
Objective: The objective of this study was to explore the therapeutic role of biomolecules in target...
The 4-hydroxyphenylpyruvate dioxygenase (HPPD) is a relevant target protein for therapeutic and ag...
[[abstract]]Phosphodiesterase 4D (PDE4D) has been identified be a promising target which associate w...
Pyruvate dehydrogenase kinases (PDKs) are key enzymes in glucose metabolism, negatively regulating p...
Parkinson’s disease (PD) is a neurodegenerative, progressive, and incurable disorder characterized b...